Skip to main content

Casey's Honored for Contributions at MDA 2019 Clinical & Scientific Conference


April 15, 2019

Who: Ankeny, IA-based Casey's General Stores Vice President of Marketing, Michael R. Richardson and the Muscular Dystrophy Association

What: Casey's Vice President of Marketing, Michael R. Richardson, accepted a special award for Casey's General Stores' unprecedented contribution to MDA's research and care programs and was presented with a white coat by MDA CEO, Lynn O'Connor Vos and Chairman of the Board R. Rodney Howell, M.D. The white coat is a symbol of service, compassion and leadership - and the commitment to an obligation to put the needs of those who are 'in need' above all others.

The coat serves as a symbol of Casey's commitment to funding treatments and cures for neuromuscular diseases since 2007. The convenience store chain has raised over $11.6 million in support of MDA's mission through in-store customer ask Summer Camp and Live Unlimited retail programs, and the Iowa Muscle Team Dinner. Casey's General Stores is the fourth largest convenience store chain, and the fifth largest pizza chain in the United States. Casey's operates some 2000 convenience stores in sixteen states.

Where: 2019 MDA Clinical & Scientific Conference, Hyatt Regency Orlando

The meeting is the preeminent gathering of the nation's leading scientists, researchers and professionals specializing in neuromuscular disease research and care, designed to accelerate discoveries and drug development for families fighting neuromuscular diseases, for which there currently are no cures. In 2019, MDA's Clinical and Scientific conferences have been combined into one annual meeting, to leverage MDA's extensive reach into the scientific, clinical research, and clinical practice communities to bring together the world's leading experts in neuromuscular disease.

When: Monday, April 15

About the Muscular Dystrophy Association

MDA is committed to transforming the lives of people affected by muscular dystrophy, ALS and related neuromuscular diseases. We do this through innovations in science and innovations in care. As the largest source of funding for neuromuscular disease research outside of the federal government, MDA has committed more than $1 billion since our inception to accelerate the discovery of therapies and cures. Research we have supported is directly linked to life-changing therapies across multiple neuromuscular diseases. MDA's MOVR is the first and only data hub that aggregates clinical, genetic and patient reported data for multiple neuromuscular diseases to improve health outcomes and accelerate drug development. MDA supports the largest network of multidisciplinary clinics providing best in class care at more than 150 of the nation's top medical institutions. Our Resource Center serves the community with one-on-one specialized support, and we offer educational conferences, events, and materials for families and healthcare providers. Each year thousands of children and young adults learn vital life skills and gain independence at summer camp and through recreational programs, at no cost to families. For more information visit

Loading, please wait.